🇺🇸 Nivolumab and Ipilimumab in United States

Nivolumab and Ipilimumab (nivolumab-and-ipilimumab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Nivolumab and Ipilimumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Nivolumab and Ipilimumab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Nivolumab and Ipilimumab in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.